Literature DB >> 4823414

Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis.

J E Sippel, I A Mikhail, N I Girgis, H H Youssef.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4823414     DOI： 10.1164/arrd.1974.109.5.579

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  10 in total

1.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

2.  Inadvertent intrathecal administration of rifampicin.

Authors:  Needhirajan Senbaga; E M Davies
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

3.  Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.

Authors:  M C Nahata; P Fan-Havard; W J Barson; H M Bartkowski; E J Kosnik
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.

Authors:  M Maduri Traczewski; D A Goldmann; P Murphy
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

5.  Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.

Authors:  N K Fujita; J E Edwards
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

Review 7.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

8.  Tuberculous meningitis: a retrospective survey of 22 cases.

Authors:  P De Domenico; R Musolino; A E Di Rosa; S Serra; M M Bonanzinga; G Gallitto; R Silvestri; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1988-10

Review 9.  Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease.

Authors:  Aashka Parikh; Christopher Vinnard; Nicole Fahrenfeld; Amy L Davidow; Amee Patrawalla; Alfred Lardizabal; Andrew Gow; Reynold Panettieri; Maria Gennaro
Journal:  Int J Environ Res Public Health       Date:  2019-11-01       Impact factor: 3.390

Review 10.  CNS tuberculosis.

Authors:  J R Sheller; R M Des Prez
Journal:  Neurol Clin       Date:  1986-02       Impact factor: 3.806
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.